PROSTATE REBIOPSY IS A POOR SURROGATE OF TREATMENT EFFICACY IN LOCALIZED PROSTATE CANCER

Authors:
  • DSDavid Svetec
    David Svetec
  • KMKEVIN McCABE
    KEVIN McCABE
  • SPSamuel Peretsman
    Samuel Peretsman
  • EKEric Klein
    Eric Klein
  • HLHoward Levin
    Howard Levin
  • SOScott Optenberg
    Scott Optenberg
  • ITIan Thompson
    Ian Thompson

Abstract
Purpose: Many investigators use prostate rebiopsy as an indicator of treatment efficacy and tumor response of localized prostate cancer for therapies in which the gland remains in situ. Bec...

This publication has 9 references indexed in Scilit: